Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402
Gregory S Hageman
United States Patent and Trademark Office
07/30/2013
Files and links (1)
pdf
Therapeutic compositions for age-related macular degeneration com1.30 MBDownloadView
The invention relates to Factor H gene polymorphisms and haplotypes associated with an elevated or a reduced risk of AMD. The invention provides methods and reagents for diagnosis and treatment of AMD.
Details
Title: Subtitle
Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402
Creators
Gregory S Hageman (Inventor)
Contributors
University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
Resource Type
Patent
Publisher
United States Patent and Trademark Office; United States
Patent
US Patent 8,497,350; United States Patent and Trademark Office (United States, Alexandria) - USPTO; Published; 12/479,716; 06/05/2009
Number of pages
144 pages
Language
English
Date published
07/30/2013
Academic Unit
UI Research Foundation
Record Identifier
9983761947502771
Metrics
12 File views/ downloads
13 Record Views
Browse by research and academic units
Browse and search our researcher profiles
Details
Therapeutic compositions for age-related macular degeneration com